SenesTech, Inc.
NNASDAQ:SNESCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Michael Edell
- Full Time Employees
- 24
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- 13430 North Dysart Road Suite 105 Surprise AZ United States 85379
- IPO Date
- Dec 8, 2016
- CIK
- 0001680378
- Website
- senestech.com
- Similar Companies
- Business
- SenesTech, Inc. is a biotechnology company specializing in the development and commercialization of innovative, environmentally-friendly pest management products primarily targeting the agricultural and urban pest control markets. The company focuses on the production and sale of its flagship product, ContraPest®, an oral baits-based rodent fertility control technology designed to humanely and effectively reduce rat populations. SenesTech also offers related pest control solutions and has expanded its product portfolio to include integrated pest management systems. Founded in 2007 and headquartered in Phoenix, Arizona, SenesTech serves customers across the United States and has ongoing efforts to expand its geographic footprint. Recent major developments for SenesTech include strategic partnerships aimed at enhancing distribution and deployment of ContraPest and related pest control products. The company has also been advancing research and development initiatives to introduce new pest management products and expand applications of its fertility control technology. These efforts include collaborations with public and private sector entities to address pest challenges in various environments. SenesTech continues to focus on sustainable and humane pest control methods as a core part of its growth strategy. SenesTech operates primarily within the biotechnology and pest management industry segments. Its target customers include agricultural producers, municipalities, food service providers, and pest control professionals. The company leverages its proprietary technology for environmentally responsible pest population control and aims to replace traditional toxic rodenticides with fertility control alternatives. SenesTech's business model emphasizes research-driven innovation, strategic alliances, and expanding market penetration in the United States and eventually internationally. The company is publicly traded under the ticker SNES.
Company News
SenesTech to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026
SenesTech Expands E-Commerce Reach Through Walmart Fulfillment Services
SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue
Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 376,552 Shares of Stock
Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Purchases 426,000 Shares of Stock
Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 181,252 Shares of Stock
GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH
GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH
SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone
Financial Analysis: Senestech (NASDAQ:SNES) & Axalta Coating Systems (NYSE:AXTA)
SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers
Senestech (NASDAQ:SNES) Shares Cross Below 50 Day Moving Average – Should You Sell?
SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference
Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
Financial Survey: Senestech (NASDAQ:SNES) & Chemtrade Logistics Income Fund (OTCMKTS:CGIFF)